1.

Record Nr.

UNINA9910984529103321

Autore

Debela Bacha Kebede

Titolo

Public Administration in Ethiopia

Pubbl/distr/stampa

Leuven University Press, 2020

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

2.

Record Nr.

UNINA9911004827603321

Autore

Burdick Donald L

Titolo

Petrochemicals in nontechnical language [[electronic resource] /] / Donald L. Burdick, William L. Leffler

Pubbl/distr/stampa

Tulsa, OK, : PennWell Corp., c2010

ISBN

1-62870-355-5

Edizione

[4th ed.]

Descrizione fisica

1 online resource (402 p.)

Altri autori (Persone)

LefflerWilliam L

Disciplina

661/.804

Soggetti

Petroleum chemicals

Petroleum products

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

Includes index.

Nota di contenuto

""CONTENTS""; ""FOREWORD""; ""PREFACE""; ""WHAT YOU NEED TO KNOW ABOUT CHEMISTRY""; ""PROCESSES AND EQUIPMENT""; ""BENZENE""; ""TOLUENE AND THE XYLENES""; ""OLEFIN PLANTS, ETHYLENE, AND PROPYLENE ""; ""CYCLOHEXANE""; ""THE C4 HYDROCARBONS FAMILY""; ""CUMENE AND PHENOL""; ""ETHYLBENZENE AND STYRENE""; ""ETHYLENE DICHLORIDE, VINYL CHLORIDE, AND EPICHLOROHYDRIN""; ""ETHYLENE OXIDE AND ETHYLENE GLYCOL""; ""PROPYLENE OXIDE AND PROPYLENE GLYCOL""; ""ETHANOLAMINES AND POLYOLS""; ""METHANOL AND SYNTHESIS GAS ""; ""FISCHER-TROPSCH PROCESS""; ""LOTS OF OTHER ALCOHOLS""; ""METHYL TERTIARY BUTYL ETHER ""



""FORMALDEHYDE AND ACETALDEHYDE""""THE KETONES: ACETONE, METHYL ETHYL KETONE, AND METHYL ISOBUTYL KETONE""; ""THE ACIDS""; ""MALEIC ANHYDRIDE""; ""ACRYLONITRILE, ACRYLIC ACID, AND THE ACRYLATES""; ""ANILINE AND PHOSGENE""; ""BISPHENOL A""; ""ALPHA OLEFINS""; ""MAKING POLYMERS""; ""THERMOPLASTICS""; ""MDI AND TDI""; ""POLYURETHANE""; ""EPOXY RESINS AND POLYCARBONATES ""; ""FIBERS AND OTHER RESINS""; ""APPENDIX: CONVERSION AND YIELD CALCULATIONS""; ""GLOSSARY""; ""INDEX""

3.

Record Nr.

UNINA9911011651003321

Autore

Ferreira Marcos Alan

Titolo

Criminal Non-State Actors : Historical Developments and Impacts in South America / / by Marcos Alan Ferreira

Pubbl/distr/stampa

Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2025

ISBN

3-031-92509-2

Edizione

[1st ed. 2025.]

Descrizione fisica

1 online resource (256 pages)

Collana

Contributions to Security and Defence Studies, , 2948-2291

Disciplina

327.116

Soggetti

Security, International

Peace

Criminology

International Security Studies

Peace and Conflict Studies

Criminology in the Global South

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Nota di contenuto

-- Introduction: criminal entities as a distinct typology of non-state actors and its role in South America.  -- Conceptualizing Criminal Non-State Actors.  -- Governance Capacities and Criminal Non-State Actors: dominating the local to expand globally.  -- Pioneering Criminal Non-State Actors in South America: the rise and downfall of Colombia drug cartels and their consequences.  -- Comando Vermelho: from a prison gang to a transnational criminal organization.  -- Brazilian Criminal Organizations as Transnational Non-State Actors: the Primeiro Comando da Capital (PCC).  -- Brazilian Amazon as locus of Criminal



Non-State Actors in South America.

Sommario/riassunto

This monograph addresses the role of criminal non-state actors in South America. In a departure from traditional analysis, the author notes that non-state actors that affect political and social life in the Global South are not always terrorist actors or the result of political disputes. In several countries, criminal actors with a high degree of complexity emerge, capable of performing violent actions that proportionally surpass the economy of crime. Furthermore, they are capable of carrying out actions beyond the state, in a transnational approach, connecting with criminal organizations in other countries and or even other violent non-state actors. This volume consolidates studies on criminal non-state actors in South America, analyzing their historical development, governance capacity, profiling key actors, and assessing their overall effect on international relations as a whole. As such, it will be useful to students and researchers interested in international security, criminology, Latin American studies, and peace and conflict studies.

4.

Record Nr.

UNINA9910974461903321

Titolo

Generating evidence for genomic diagnostic test development : workshop Summary / / Theresa Wizemann and Adam C. Berger, rapporteurs ; Roundtable on translating Genomic-Based Research for Health, Board on Health Sciences Policy, Institute of Medicine of the National Academies

Pubbl/distr/stampa

Washington, D.C., : National Academies Press, 2011

ISBN

0-309-21107-7

1-283-21343-5

9786613213433

0-309-21105-0

Edizione

[1st ed.]

Descrizione fisica

1 online resource (100 p.)

Altri autori (Persone)

WizemannTheresa M

BergerAdam C

Disciplina

616.0420027

Soggetti

Genomics

Diagnosis

Gene mapping

Lingua di pubblicazione

Inglese



Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

Description based upon print version of record.

Nota di bibliografia

Includes bibliographical references.

Nota di contenuto

""Front Matter""; ""Reviewers""; ""Acknowledgments""; ""Contents""; ""Tables, Figures, and Boxes""; ""Abbreviations and Acronyms""; ""1 Introduction""; ""2 Stakeholder Perspectives on Evidence""; ""3 Approaches to Evidence Generation""; ""4 Overcoming Barriers for Evidence Generation""; ""5 Considerations Moving Forward""; ""6 Final Remarks""; ""References""; ""Appendix A: Workshop Agenda""; ""Appendix B: Speaker Biographical Sketches""; ""Appendix C: Registered Attendees""

Sommario/riassunto

"Ten years after the sequencing of the human genome, scientists have developed genetic tests that can predict a person's response to certain drugs, estimate the risk of developing Alzheimer's disease, and make other predictions based on known links between genes and diseases. However, genetic tests have yet to become a routine part of medical care, in part because there is not enough evidence to show they help improve patients' health.The Institute of Medicine (IOM) held a workshop to explore how researchers can gather better evidence more efficiently on the clinical utility of genetic tests. Generating Evidence for Genomic Diagnostic Test Development compares the evidence that is required for decisions regarding clearance, use, and reimbursement, to the evidence that is currently generated. The report also addresses innovative and efficient ways to generate high-quality evidence, as well as barriers to generating this evidence. Generating Evidence for Genomic Diagnostic Test Development contains information that will be of great value to regulators and policymakers, payers, health-care providers, researchers, funders, and evidence-based review groups."--Publisher's description.